Caribou Biosciences (NASDAQ:CRBU) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Caribou Biosciences (CRBU) operate in?

Caribou Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Caribou Biosciences Stock (NASDAQ: CRBU) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.16M
Day Range	- - -
52 Wk Range	1.50 - 8.33
Market Cap	$177.48M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	11.5%
Days to Cover	10.12

Recent News

Attention Biotech Investors - Stocks To Watch From RBC Global Healthcare Conference

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts, McCarthy highlights Agios Pharmaceuticals, Caribou Biosciences, and Corbus Pharmaceuticals with key 2024 data readouts and trials.

Vandana Singh

Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.

Avi Kapoor

Investor Sentiment Improves Following Inflation Data, Dow Jumps Over 200 Points

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, but the index remained in the "Greed" zone on Tuesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.16M
Day Range	- - -
52 Wk Range	1.50 - 8.33
Market Cap	$177.48M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	11.5%
Days to Cover	10.12

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Caribou Biosciences (CRBU) stock?

You can purchase shares of Caribou Biosciences (NASDAQ:CRBU) through any online brokerage.

View our list of the best stock brokerages

Who are Caribou Biosciences (CRBU) competitors?

Other companies in Caribou Biosciences’s space includes: Molecular Partners (NASDAQ:MOLN), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY), Adaptimmune Therapeutics (NASDAQ:ADAP) and Kyverna Therapeutics (NASDAQ:KYTX).

What is the forecast, or price target, for Caribou Biosciences (CRBU) stock?

Caribou Biosciences has a consensus price target of $23.57.

What is the current price for Caribou Biosciences (CRBU)?

The stock price for Caribou Biosciences (NASDAQ: CRBU) is $1.96 last updated November 20, 2024 at 4:20 PM EST.

Does Caribou Biosciences (CRBU) pay a dividend?

There are no upcoming dividends for Caribou Biosciences.

When is Caribou Biosciences (NASDAQ:CRBU) reporting earnings?

Caribou Biosciences’s Q3 earnings are confirmed for Wednesday, November 6, 2024.

Is Caribou Biosciences (CRBU) going to split?

There is no upcoming split for Caribou Biosciences.

What sector and industry does Caribou Biosciences (CRBU) operate in?

Caribou Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Caribou Biosciences

Caribou Biosciences (CRBU) Forecast